Skip to main content
. 2021 May 17;112(4):576–586. doi: 10.17269/s41997-021-00531-6

Table 2.

Association between symptoms and anti-SARS-CoV-2 seroprevalence test results, based on a univariate logistic regression model

Questions on symptoms occurring between March 1, 2020 and 14 days before blood donation date Answers Number of individuals (%) Unadjusted analysis Age- and sex-adjusted analysis
Antibody-positive
(n = 161)
Negative controls
(n = 162)
OR 95% CI OR 95% CI
Sick, and presenting symptoms similar to those reported for COVID-19† Yes 60 (37.3) 11 (6.8) 8.4 4.2–16.7 7.9 3.9–15.8
No 98 (60.9) 150 (92.6)
Do not know 3 (1.9) 1 (0.6)
Fever (≥38°C) or sensation of fever/chills Yes 39 (24.2) 3 (1.9) 16.9 5.1–55.9 15.1 4.5–50.3
No 121 (75.2) 157 (96.9)
Do not know 1 (0.6) 1 (0.6)
Weakness Yes 36 (22.4) 6 (3.7) 7.4 3.0–18.2 7.1 2.9–17.5
No 125 (77.6) 155 (95.7)
Do not know 0 (0.0) 1 (0.6)
Generalized pain (myalgia, arthralgia) Yes 23 (14.3) 3 (1.9) 8.9 2.6–30.3 8.4 2.4–28.8
No 136 (84.5) 158 (97.5)
Do not know 2 (1.2) 1 (0.6)
Rhinorrhea Yes 28 (17.4) 17 (10.5) 1.82 0.95–3.5 1.76 0.92–3.4
No 131 (81.4) 145 (89.5)
Do not know 2 (1.2) 0 (0.0)
Sore throat Yes 34 (21.1) 13 (8.0) 3.1 1.56–6.1 2.9 1.45–5.8
No 126 (78.3) 149 (92.0)
Do not know 1 (0.6) 0 (0.0)
Cough Yes 28 (17.4) 8 (4.9) 4.1 1.81–9.3 4.2 1.81–9.5
No 131 (81.4) 154 (95.1)
Do not know 2 (1.2) 0 (0.0)
Shortness of breath/difficulty breathing Yes 22 (13.7) 3 (1.9) 8.5 2.5–28.8 8.0 2.3–27.5
No 138 (85.7) 159 (98.1)
Do not know 1 (0.6) 0 (0.0)
Loss or reduction in smell or taste sensation Yes 25 (15.5) 1 (0.6) 30.0 4.0–224.6 27.6 3.7–207.9
No 134 (83.2) 161 (99.4)
Do not know 2 (1.2) 0 (0.0)
Diarrhea Yes 27 (16.8) 9 (5.6) 3.5 1.59-7.7 3.5 1.57–7.7
No 131 (81.4) 153 (94.4)
Do not know 3 (1.9) 0 (0.0)
At least one symptom‡ Yes 84 (52.2) 31 (19.1) 4.6 2.8–7.6 4.9 2.9–8.1
No 77 (47.8) 131 (80.9)
At least one symptom, excluding rhinorrhea Yes 80 (49.7) 29 (17.9) 4.5 2.7–7.5 4.6 2.8–7.8
No 81 (50.3) 133 (82.1)

OR, odds ratio

†Individuals for whom symptom onset occurred after blood donation were classified in the “no” group

‡Symptoms confirmed following interview with a nurse